47 results on '"Imig, John D."'
Search Results
2. A DUAL COX‐2/sEH INHIBITOR TREATED KIDNEY INJURY IN A DRUG‐INDUCED GLOMERULAR DISEASE MODEL
3. DUAL ACTING COX‐2 AND SOLUBLE EPOXIDE HYDROLASE INHIBITOR ATTENUATES GLOMERULAR INJURY IN FOCAL SEGMENTAL GLOMERULAR SCLEROSIS
4. REVERSAL OF UNILATERAL URETERAL OBSTRUCTION LEADS TO SALT‐SENSITIVE HYPERTENSION
5. Fructose Consumption Increases Blood Pressure and Induces Changes in Renal Microvascular Function
6. A Novel Dual Soluble Epoxide Hydrolase Inhibitor/Cyclooxygenase‐2 Inhibitor Treats Type 2 Diabetic Complications in Obese ZSF1 Rats
7. A Dual Farnesoid X Receptor Agonist /Soluble Epoxide Hydrolase Inhibitor Prevents Non‐Alcoholic Steatohepatitis in Mice
8. EET Analogs and the Dual‐Inhibition of sEH/COX‐2 for the Treatment of Focal Segmental Glomerular Sclerosis
9. Glomerular Mesangial Proliferation is Mitigated by sEH/COX‐2 Dual‐Inhibition
10. A Dual Soluble Epoxide Hydrolase Inhibitor/PPAR‐γ Agonist Prevents Renal Fibrosis in Mouse Unilateral Ureteral Obstruction Model
11. The Effect of Voltage‐Sensitive Chloride Channel 6 on Development of Salt‐Sensitive Hypertension
12. Determining the Contribution of Mast Cell‐specific Neurokinin‐1 Receptors in Pressure Overload‐Induced Cardiac Fibrosis
13. An epoxyeicosatrienoic acid analog treated adriamycin‐induced proteinuria and renal fibrosis
14. Epoxyeicosatrienoic Acid Analog Reduces Proteinuria And Renal Cast Formation In Experimental Radiation Nephropathy
15. Dual Soluble Epoxide Hydrolase Inhibitor/PPAR‐γ Agonist Reduces Kidney Injury In Metabolic Syndrome Rat
16. Novel Omega‐3 Fatty Acid Epoxygenase Metabolite Reduces Kidney Fibrosis
17. Radiation‐induced Afferent Arteriolar Endothelial Dysfunction Involves Decreased Epoxygenase Metabolites
18. Epoxyeicosatrienoic Acid Analogs Reduce Renal Fibrosis By Reducing Epithelial‐To Mesenchymal‐Transition
19. Novel orally active epoxyeicosatrienoic acid (EET) analogs attenuate cisplatin nephrotoxicity
20. A novel epoxyeicosatrienoic acid analog attenuates hypertension and renal injury in Cyp2c44 KO mice
21. Novel Orally Active Epoxyeicosatrienoic Acid (EET) Analogs Attenuate Cisplatin Nephrotoxicity
22. Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.
23. Endothelial expression of human cytochrome P450 epoxygenases lowers blood pressure and attenuates hypertension‐induced renal injury in mice
24. Impaired mesenteric resistance artery relaxation to KATP channel activation in cardiometabolic syndrome is improved by rosiglitazone treatment
25. Vascular Endothelial Growth Factor (VEGF) Inhibitors Induce Hypertension, Afferent Arteriolar Dysfunction, and Glomerular Injury
26. Attenuated endothelin‐1 (ET‐1) vasoconstrictor responses in cardiometabolic syndrome are attributed to increased ET‐B receptors
27. Soluble Epoxide Hydrolase Inhibition (SEHi) and Thiazolidinedione (TZD) in combination provide greater renal injury protection in Spontaneously Hypertensive Obese (SHROB) Rats.
28. SPARC deficiency ameliorates renal damage resulting from angiotensin II and a high salt diet
29. Epoxyeicosatrienoic acids (EET) contribute to flow‐induced dilation in mice mesenteric resistance artery
30. Development of combined soluble epoxide hydrolase inhibitors and epoxide analogs with vasodilator activity
31. 8,9‐Dihydroxyeicosatrienoic acid does not protect the glomerular filtration barrier
32. Renal mechanisms of antihypertensive effects caused by inhibition of soluble epoxide hydrolase in Cyp1a1‐Ren‐2 transgenic rats.
33. Increased blood pressure in mice lacking cytochrome P450 2J5
34. Ether epoxyeicosatrienoic acid (EET) analogs lower blood pressure when administered in‐vivo to the spontaneously hypertensive rats
35. The divergent role of epoxyeicosatrienoic acids in the regulation of renal function in normotensive and two‐kidney one‐clip Goldblatt hypertensive rats
36. Soluble Epoxide Inhibition Differentially Modulates Flow Induced Vascular Remodeling in Spontaneously Hypertensive Stroke Prone Rats and Wistar Kyoto Rats
37. Simvastatin and Tempol Protect Against Endothelial Dysfunction and Renal Injury in a Model of Obesity and Hypertension
38. Soluble epoxide hydrolase inhibition attenuates the development of renovascular hypertension in 2K1C rats.
39. Soluble epoxide hydrolase inhibitor improves cardiac ischemic tolerance in Ren‐2 transgenic rats
40. Soluble Epoxide Hydrolase Inhibition Modulates Gene Expression of Anti‐Apoptotic and Apoptotic Factors
41. High fat diet induces insulin resistance and heightened renal inflammation in angiotensin II hypertensive rats
42. Dietary fat increases renal injury in SHR in the absence of changes in insulin sensitivity or blood pressure
43. Long‐term high fat diet treatment activates NF kappa B signaling and increases endothelial dysfunction in angiotensin II hypertensive rats
44. Peroxisome proliferators‐activated receptor‐alpha activation increases renal CYP2C23 and decreases cyclin D1 and blood pressure in Zucker diabetic fatty rats
45. Rosaglitazone (RGZ) decreases renal damage in spontaneously diabetic Goto‐Kakizaki (GK) rats
46. Urea‐based soluble epoxide hydrolase inhibitors dilate mesenteric resistance vessels
47. Cytochrome P450 epoxygenases provide a novel mechanism for penile erection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.